1. Home
  2. GDC vs ALLK Comparison

GDC vs ALLK Comparison

Compare GDC & ALLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDC
  • ALLK
  • Stock Information
  • Founded
  • GDC 2015
  • ALLK 2012
  • Country
  • GDC United States
  • ALLK United States
  • Employees
  • GDC N/A
  • ALLK N/A
  • Industry
  • GDC Steel/Iron Ore
  • ALLK Biotechnology: Pharmaceutical Preparations
  • Sector
  • GDC Industrials
  • ALLK Health Care
  • Exchange
  • GDC Nasdaq
  • ALLK Nasdaq
  • Market Cap
  • GDC 32.7M
  • ALLK 23.0M
  • IPO Year
  • GDC N/A
  • ALLK 2018
  • Fundamental
  • Price
  • GDC $2.49
  • ALLK $0.33
  • Analyst Decision
  • GDC
  • ALLK Hold
  • Analyst Count
  • GDC 0
  • ALLK 3
  • Target Price
  • GDC N/A
  • ALLK $2.00
  • AVG Volume (30 Days)
  • GDC 55.4K
  • ALLK 2.3M
  • Earning Date
  • GDC 05-19-2025
  • ALLK 05-08-2025
  • Dividend Yield
  • GDC N/A
  • ALLK N/A
  • EPS Growth
  • GDC N/A
  • ALLK N/A
  • EPS
  • GDC N/A
  • ALLK N/A
  • Revenue
  • GDC N/A
  • ALLK N/A
  • Revenue This Year
  • GDC N/A
  • ALLK N/A
  • Revenue Next Year
  • GDC N/A
  • ALLK N/A
  • P/E Ratio
  • GDC N/A
  • ALLK N/A
  • Revenue Growth
  • GDC N/A
  • ALLK N/A
  • 52 Week Low
  • GDC $0.59
  • ALLK $0.22
  • 52 Week High
  • GDC $12.18
  • ALLK $1.56
  • Technical
  • Relative Strength Index (RSI)
  • GDC 56.67
  • ALLK 61.98
  • Support Level
  • GDC $2.00
  • ALLK $0.31
  • Resistance Level
  • GDC $2.84
  • ALLK $0.33
  • Average True Range (ATR)
  • GDC 0.32
  • ALLK 0.01
  • MACD
  • GDC -0.01
  • ALLK 0.01
  • Stochastic Oscillator
  • GDC 61.54
  • ALLK 96.36

About GDC GD Culture Group Limited

GD Culture Group Ltd focuses its business on two segments mainly through the Company and two subsidiaries. 1) AI-driven digital human creation and customization; 2) Live streaming and e-commerce. The company has relentlessly been focusing on serving its customers and creating value for them through the continual innovation and optimization of its products and services. For the AI-driven digital human creation and customization sector, the Company uses AI algorithms and software to generate realistic 3D or 2D digital human models. AI algorithms and machine learning models are used to simulate human characteristics, such as facial expressions, body movements, and even speech patterns.

About ALLK Allakos Inc.

Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation. Its portfolio consists of antibodies that target receptors, particularly Siglec-6, Siglec-8 and other anti-Siglec antibodies, including some antibodies in preclinical development.

Share on Social Networks: